Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul M Stranges

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Clinical Diabetes : a Publication of the American Diabetes Association|July 2, 2015
End of the Road: Diabetes Care When Insulin May Not Be an OptionPaul M Stranges, Jeffrey M Tingen
Journal of the American College of Clinical Pharmacy : JACCP|April 20, 2026
Embracing Pharmacists' Opportunities to Improve Care for People Living With Substance Use DisordersKirk E Evoy, Paul M Stranges
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 5, 2016
Impact of resident research publication on early-career publication successPaul M Stranges, Scott Martin Vouri
Pharmacy Practice|July 11, 2017
Impact of co-investigators on pharmacy resident research publicationPaul M Stranges, Scott M Vouri
Journal of Pharmacy Practice|October 2, 2015
Comments on: Validity and Reliability of a Systematic Database Search Strategy to Identify Publications Resulting From Pharmacy Residency Research ProjectsScott Martin Vouri, Paul M Stranges, Jill Nissen
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 30, 2013
Cost-effectiveness analysis evaluating fidaxomicin versus oral vancomycin for the treatment of Clostridium difficile infection in the United StatesPaul M Stranges, David W Hutton, Curtis D Collins
Archives of Gerontology and Geriatrics|November 28, 2016
Adverse events and treatment discontinuations of antimuscarinics for the treatment of overactive bladder in older adults: A systematic review and meta-analysisScott Martin Vouri, Clark D Kebodeaux, Paul M Stranges, et al.
The Annals of Pharmacotherapy|December 18, 2014
Treatment of hypertension with chronotherapy: is it time of drug administration?Paul M Stranges, Amy M Drew, Patricia Rafferty, et al.
Currents in Pharmacy Teaching & Learning|December 14, 2017
Faculty perception of team-based learning over multiple semestersClark D Kebodeaux, Golden L Peters, Paul M Stranges, et al.
Journal of Substance Use and Addiction Treatment|December 7, 2023
Cost-effectiveness of full and partial opioid agonists for opioid use disorder in outpatient settings: United States healthcare sector perspectiveSun A Choi, Connie H Yan, Nicole M Gastala, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Clinical Diabetes : a Publication of the American Diabetes Association|July 2, 2015
End of the Road: Diabetes Care When Insulin May Not Be an OptionPaul M Stranges, Jeffrey M Tingen
Journal of the American College of Clinical Pharmacy : JACCP|April 20, 2026
Embracing Pharmacists' Opportunities to Improve Care for People Living With Substance Use DisordersKirk E Evoy, Paul M Stranges
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 5, 2016
Impact of resident research publication on early-career publication successPaul M Stranges, Scott Martin Vouri
Pharmacy Practice|July 11, 2017
Impact of co-investigators on pharmacy resident research publicationPaul M Stranges, Scott M Vouri
Journal of Pharmacy Practice|October 2, 2015
Comments on: Validity and Reliability of a Systematic Database Search Strategy to Identify Publications Resulting From Pharmacy Residency Research ProjectsScott Martin Vouri, Paul M Stranges, Jill Nissen
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 30, 2013
Cost-effectiveness analysis evaluating fidaxomicin versus oral vancomycin for the treatment of Clostridium difficile infection in the United StatesPaul M Stranges, David W Hutton, Curtis D Collins
Archives of Gerontology and Geriatrics|November 28, 2016
Adverse events and treatment discontinuations of antimuscarinics for the treatment of overactive bladder in older adults: A systematic review and meta-analysisScott Martin Vouri, Clark D Kebodeaux, Paul M Stranges, et al.
The Annals of Pharmacotherapy|December 18, 2014
Treatment of hypertension with chronotherapy: is it time of drug administration?Paul M Stranges, Amy M Drew, Patricia Rafferty, et al.
Currents in Pharmacy Teaching & Learning|December 14, 2017
Faculty perception of team-based learning over multiple semestersClark D Kebodeaux, Golden L Peters, Paul M Stranges, et al.
Journal of Substance Use and Addiction Treatment|December 7, 2023
Cost-effectiveness of full and partial opioid agonists for opioid use disorder in outpatient settings: United States healthcare sector perspectiveSun A Choi, Connie H Yan, Nicole M Gastala, et al.
Pageof 2